EyeTel Imaging, Inc.

Retinal risk assessment technology aids in detection of eye disease

Published in Telemedicine Business Week, May 5th, 2004

EyeTel Imaging, Inc., announced that it has formally launched DigiScope, a U.S. Food and Drug Administration (FDA)-cleared for marketing device that physicians can use to detect early-stage diabetic retinopathy, the leading cause of vision loss in adults of working age in the U.S.

The only device designed to be economical and functional in a primary care physician's office, DigiScope has been shown to be equivalent to 7-field fundus photography, the current "gold standard" for detecting diabetic retinopathy, one of the devastating microvascular complications currently facing people with diabetes worldwide. DigiScope is also the only device specifically designed for ease...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Telemedicine Business Week

Source: Telemedicine Business Week (2004-05-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry